According to Cytek Biosciences's latest financial reports the company's current EPS (TTM) is -HK$0.31. In 2022 the company made an earnings per share (EPS) of HK$0.12 an increase over its 2021 EPS that were of HK$0.02486.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$0.31 | -360.02% |
2022 | HK$0.12 | 386.88% |
2021 | HK$0.02486 | -97.27% |
2020 | HK$0.91 |